Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 4 |
2021 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion.
Am J Cancer Res. 2022 Feb 15;12(2):469-489. eCollection 2022.
Am J Cancer Res. 2022.
PMID: 35261781
Free PMC article.
Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer.
Elsharawy KA, Althobiti M, Mohammed OJ, Aljohani AI, Toss MS, Green AR, Rakha EA.
Elsharawy KA, et al. Among authors: aljohani ai.
Breast Cancer Res Treat. 2021 Feb;185(3):615-627. doi: 10.1007/s10549-020-05999-3. Epub 2020 Nov 8.
Breast Cancer Res Treat. 2021.
PMID: 33161513
Free PMC article.
Item in Clipboard
The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
Aljohani AI, Toss MS, Kurozumi S, Joseph C, Aleskandarany MA, Miligy IM, Ansari RE, Mongan NP, Ellis IO, Green AR, Rakha EA.
Aljohani AI, et al.
Breast Cancer Res Treat. 2020 Jan;179(1):79-90. doi: 10.1007/s10549-019-05459-7. Epub 2019 Oct 10.
Breast Cancer Res Treat. 2020.
PMID: 31599393
Free PMC article.
Item in Clipboard
The expression of high mobility group protein 3 (HMGB3) in breast cancer with emphasis on its role in lymphovascular invasion.
Aljohani AI, Alsaeed SA, Toss MS, Raafat SA, Green AR, Rakha EA.
Aljohani AI, et al.
Am J Cancer Res. 2023 Nov 15;13(11):5334-5351. eCollection 2023.
Am J Cancer Res. 2023.
PMID: 38058796
Free PMC article.
Item in Clipboard
The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
Aljohani AI, Toss MS, Green AR, Rakha EA.
Aljohani AI, et al.
Breast Cancer Res Treat. 2023 Apr;198(3):423-435. doi: 10.1007/s10549-022-06801-2. Epub 2022 Nov 22.
Breast Cancer Res Treat. 2023.
PMID: 36418517
Free PMC article.
Item in Clipboard
The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma.
Joseph C, Alsaleem MA, Toss MS, Kariri YA, Althobiti M, Alsaeed S, Aljohani AI, Narasimha PL, Mongan NP, Green AR, Rakha EA.
Joseph C, et al. Among authors: aljohani ai.
Cancers (Basel). 2020 Dec 30;13(1):80. doi: 10.3390/cancers13010080.
Cancers (Basel). 2020.
PMID: 33396670
Free PMC article.
Item in Clipboard
Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.
Aljohani AI, Joseph C, Kurozumi S, Mohammed OJ, Miligy IM, Green AR, Rakha EA.
Aljohani AI, et al.
Breast Cancer Res Treat. 2020 Jun;181(3):541-551. doi: 10.1007/s10549-020-05646-x. Epub 2020 Apr 29.
Breast Cancer Res Treat. 2020.
PMID: 32350677
Free PMC article.
Item in Clipboard
Cite
Cite